CA-125 IN OVARIAN-CANCER

被引:0
作者
VANDERBURG, MEL [1 ]
LAMMES, FB [1 ]
VERWEIJ, J [1 ]
机构
[1] UNIV AMSTERDAM, ACAD MED CTR, DEPT GYNAECOL ONCOL, 1105 AZ AMSTERDAM, NETHERLANDS
关键词
OVARIAN CANCER; TUMOR MARKER; CA-125;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:36 / 51
页数:16
相关论文
共 50 条
  • [41] Targeting CA-125 Transcription by Development of a Conditionally Replicative Adenovirus for Ovarian Cancer Treatment
    Yue, Er
    Yang, Guangchao
    Yao, Yuanfei
    Wang, Guangyu
    Mohanty, Atish
    Fan, Fang
    Zhao, Ling
    Zhang, Yanqiao
    Mirzapoiazova, Tamara
    Walser, Tonya C.
    Rodriguez-Rodriguez, Lorna
    Fong, Yuman
    Salgia, Ravi
    Wang, Edward Wenge
    CANCERS, 2021, 13 (17)
  • [42] In silico designed mRNA vaccines targeting CA-125 neoantigen in breast and ovarian cancer
    Lu, Lingeng
    Ma, Wenxue
    Johnson, Caroline H.
    Khan, Sajid A.
    Irwin, Melinda L.
    Pusztai, Lajos
    VACCINE, 2023, 41 (12) : 2073 - 2083
  • [43] Assessment of CA-125 area under the curve as a prognostic factor in patients with ovarian cancer
    Uzunoglu, Sernaz
    Aybatli, Aysun
    Kaplan, Petek Balkanli
    Cicin, Irfan
    Sut, Necdet
    Sayin, Cenk
    Varol, Fusun
    MEDICAL ONCOLOGY, 2013, 30 (01)
  • [44] USEFULNESS OF IMAGING OVARIAN-CANCER RECURRENCE WITH IN-111 LABELED MONOCLONAL-ANTIBODY (OC-125) SPECIFIC FOR CA-125 ANTIGEN
    PELTIER, P
    DUTIN, JP
    CHATAL, JF
    FUMOLEAU, P
    BOURGUET, P
    LIEHN, JC
    VUILLEZ, JP
    HERRY, JY
    LOBOGUERRERO, A
    ANNALS OF ONCOLOGY, 1993, 4 (04) : 307 - 311
  • [45] Nadir CA-125 Level Is an Independent Prognostic Factor in Advanced Epithelial Ovarian Cancer
    Kang, Sokbom
    Seo, Sang-Soo
    Park, Sang-Yoon
    JOURNAL OF SURGICAL ONCOLOGY, 2009, 100 (03) : 244 - 247
  • [46] Ultrasound molecular imaging of ovarian cancer with CA-125 targeted nanobubble contrast agents
    Gao, Yong
    Hernandez, Christopher
    Yuan, Hai-Xia
    Lilly, Jacob
    Kota, Pavan
    Zhou, Haoyan
    Wu, Hanping
    Exner, Agata A.
    NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2017, 13 (07) : 2159 - 2168
  • [47] Modulation of CA-125 tumor marker shedding in ovarian cancer cells by erlotimb or cetuximab
    Marth, Christian
    Egle, Daniel
    Auer, Doris
    Roessler, Julia
    Zeimet, Alain G.
    Vergote, Ignace
    Daxenbichler, Guenter
    GYNECOLOGIC ONCOLOGY, 2007, 105 (03) : 716 - 721
  • [48] Abnormal CA-125 levels in menopausal women without ovarian cancer
    Terada, Keith Y.
    Elia, Jennifer
    Kim, Robert
    Carney, Michael
    Ahn, Hyeong Jun
    GYNECOLOGIC ONCOLOGY, 2014, 135 (01) : 34 - 37
  • [49] Complement-inhibiting effect of ovarian cancer antigen CA-125
    Murdoch, WJ
    Van Kirk, EA
    Smedts, AM
    CANCER LETTERS, 2006, 236 (01) : 54 - 57
  • [50] CA125 PARAMETERS IN SURVIVORS AND NONSURVIVORS WITH EPITHELIAL OVARIAN-CANCER
    CRUICKSHANK, DJ
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 1991, 1 (06) : 279 - 284